iSpecimen Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
iSpecimen Inc. (ISPC) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $100.02 per share as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2025-08-14
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $100.02.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $107.76.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $132.34.
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $111.14.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value as first filed |
|---|---|---|
| 2025-06-30 | $100.02 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $107.76 10-Q · filed 2025-05-19 | |
| 2024-12-31 | $132.34 10-Q · filed 2025-08-14 | |
| 2024-09-30 | $111.14 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.67 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $5.78 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $113.09 10-Q · filed 2025-08-14 | $5.67 10-K · filed 2024-03-13 |
| 2023-09-30 | $5.68 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $5.47 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $5.46 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $5.43 10-K · filed 2024-03-13 | |
| 2022-09-30 | $5.75 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $5.80 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $6.68 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $6.78 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |